Marko Pesu
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- interferon and immune responses
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions
Papers in
- Immunology 29
- T-cell and B-cell Immunology 8
- Immune Cell Function and Interaction 6
- interferon and immune responses 5
-
- NF-κB Signaling Pathways 6
- Co-authors
- John J. O’SheaOlli SilvennoinenSaara AittomäkiPipsa SaharinenKunihiro YamaokaPaul S. ChangelianDominic BorieJohn Andersson
- Journals
- The Journal of Immunology (4 papers)Scientific Reports (2 papers)The Journal of Experimental Medicine (2 papers)Basic & Clinical Pharmacology & Toxicology (2 papers)Applied and Environmental Microbiology (2 papers)
- Partner nations
- FinlandUnited StatesItaly
In The Last Decade
Marko Pesu
62 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 111
- Immunology 1.3k
- Oncology 1.0k
- Genetics 315
- Rheumatology 323
- Hematology 219
Countries citing papers authored by Marko Pesu
This map shows the geographic impact of Marko Pesu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Pesu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Pesu more than expected).
Fields of papers citing papers by Marko Pesu
This network shows the impact of papers produced by Marko Pesu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Pesu. The network helps show where Marko Pesu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marko Pesu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 12 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 25 | |
| 6 | 2021 | 3 | |
| 7 | 2018 | 12 | |
| 8 | Proprotein convertase enzyme FURIN is upregulated in primary Sjögren's syndrome. | 2018 | 16 |
| 9 | 2017 | 11 | |
| 10 | 2015 | 30 | |
| 11 | 2014 | 26 | |
| 12 | 2014 | 34 | |
| 13 | 2013 | 18 | |
| 14 | 2013 | 47 | |
| 15 | 2012 | 8 | |
| 16 | 2012 | 103 | |
| 17 | 2011 | 17 | |
| 18 | [T-helper cells--bandleaders of immune response]. | 2010 | 4 |
| 19 | 2004 | 489 | |
| 20 | 2000 | 68 |
About Marko Pesu
Marko Pesu is a scholar working on Immunology, Cancer Research, Oncology, Parasitology and Pharmacology, having authored 62 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (13 papers), T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (6 papers), NF-κB Signaling Pathways (6 papers), interferon and immune responses (5 papers), Ubiquitin and proteasome pathways (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.0k citations), Genetics (315 citations), Rheumatology (323 citations) and Hematology (219 citations). Marko Pesu has collaborated with scholars based in Finland, United States and Italy. Frequent co-authors include John J. O’Shea, Olli Silvennoinen, Saara Aittomäki, Pipsa Saharinen, Kunihiro Yamaoka, Paul S. Changelian, Dominic Borie, John Andersson, Ethan M. Shevach and Arian Laurence. Their work appears in journals such as The Journal of Immunology, Scientific Reports, The Journal of Experimental Medicine, Basic & Clinical Pharmacology & Toxicology and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.